FHI 360 Leadership in Contraceptive Technology Innovation Through Envision FP Award From USAID
August 26, 2015 —
DURHAM, NC — FHI 360, which has been a global leader in family planning (FP) research for more than four decades, has received Envision FP: Transforming Contraception to Expand Access and Choice, a new five-year award from the U.S. Agency for International Development (USAID). Under Envision FP, USAID’s flagship contraceptive technology research project, FHI 360 will develop, introduce and expand understanding of family planning methods to enhance choice and reduce unmet need worldwide.
The Envision FP project will be directed by Dr. Laneta Dorflinger, Distinguished Scientist and Director of Contraceptive Technology Innovation (CTI) at FHI 360. Dr. Gregory S. Kopf, Director of Research and Development of CTI, will also serve on the project’s management team. “We envision a world in which all individuals and families have access to an expanded range of highly effective and safe contraceptive methods to meet changing needs throughout their reproductive lives,” said Dr. Dorflinger. “Family planning is unequivocally one of the most cost-effective interventions available to improve maternal and child health and reduce unintended pregnancies and abortions. However, there are more than 220 million women in developing countries who want to avoid or delay pregnancy but are not using modern contraceptives, often because the products currently available do not meet their needs or preferences.”